Riociguat for the treatment of pulmonary arterial hypertension (PAH): 2-year results from the PATENT-2 long-term extension - Ghofrani, Hossein Ardeschir; Grünig, Ekkehard (BMC pharmacology & toxicology, 2017)
Gesehen am 15.02.2018